المؤلفون: Luminari, Stefano, Fossa, Alexander, Trotman, Judith, Molin, Daniel, d'Amore, Francesco, Enblad, Gunilla, Berkahn, Leanne, Barrington, Sally F, Radford, John, Federico, Massimo, Kirkwood, Amy A, Johnson, Peter W M

المصدر: Luminari , S , Fossa , A , Trotman , J , Molin , D , d'Amore , F , Enblad , G , Berkahn , L , Barrington , S F , Radford , J , Federico , M , Kirkwood , A A & Johnson , P W M 2024 , ' Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial ' , Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol. 42 , no. 1 , pp. 13-18 . https://doi.org/10.1200/JCO.23.01177Test

مصطلحات موضوعية: Adult, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Bleomycin/adverse effects, Cyclophosphamide/therapeutic use, Dacarbazine/adverse effects, Doxorubicin/adverse effects, Follow-Up Studies, Hodgkin Disease/pathology, Humans, Neoplasms, Second Primary/drug therapy, Prednisone/therapeutic use, Vinblastine/adverse effects, Vincristine/adverse effects

العلاقة: https://research.manchester.ac.uk/en/publications/ea662d75-c32b-4e84-8764-7ab9941591baTest

الإتاحة: https://doi.org/10.1200/JCO.23.01177Test
https://research.manchester.ac.uk/en/publications/ea662d75-c32b-4e84-8764-7ab9941591baTest
http://www.scopus.com/inward/record.url?scp=85180566434&partnerID=8YFLogxKTest
https://www.mendeley.com/catalogue/5aece9b8-c011-321f-b711-694186e0be0eTest/

المؤلفون: Smabers, Lidwien P, Wensink, Emerens, Verissimo, Carla S, Koedoot, Esmee, Pitsa, Katerina-Chara, Huismans, Maarten A, Higuera Barón, Celia, Doorn, Mayke, Valkenburg-van Iersel, Liselot B, Cirkel, Geert A, Brousali, Anneta, Overmeer, René, Koopman, Miriam, Braat, Manon N, Penning de Vries, Bas, Elias, Sjoerd G, Vries, Robert G, Kranenburg, Onno, Boj, Sylvia F, Roodhart, Jeanine M

المصدر: Smabers , L P , Wensink , E , Verissimo , C S , Koedoot , E , Pitsa , K-C , Huismans , M A , Higuera Barón , C , Doorn , M , Valkenburg-van Iersel , L B , Cirkel , G A , Brousali , A , Overmeer , R , Koopman , M , Braat , M N , Penning de Vries , B , Elias , S G , Vries , R G , Kranenburg , O , Boj , S F & Roodhart , J M 2024 , ' Organoids as a ....

مصطلحات موضوعية: Cancer, Chemotherapy, Colorectal cancer, Drug screening, Oncology, Organoids, Precision medicine, Humans, Irinotecan/pharmacology therapeutic use, Oxaliplatin/pharmacology therapeutic use, Colorectal Neoplasms/drug therapy genetics, Acetylcysteine/therapeutic use, Fluorouracil/pharmacology therapeutic use, Colonic Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/8bfe0b17-e7ae-48ee-b21f-f9d5074cf3d1Test

الإتاحة: https://doi.org/10.1186/s13046-024-02980-6Test
https://cris.maastrichtuniversity.nl/en/publications/8bfe0b17-e7ae-48ee-b21f-f9d5074cf3d1Test

المؤلفون: Pedersen, Mette Abildgaard, Gormsen, Lars C, Jakobsen, Lasse H, Eyre, Toby A, Severinsen, Marianne T, Baech, Joachim, Dann, Eldad J, Knapp, Andrea, Sahin, Denis, Vestergaard, Peter, El-Galaly, Tarec C, Jensen, Paw

المصدر: Pedersen , M A , Gormsen , L C , Jakobsen , L H , Eyre , T A , Severinsen , M T , Baech , J , Dann , E J , Knapp , A , Sahin , D , Vestergaard , P , El-Galaly , T C & Jensen , P 2024 , ' The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study ' , British Journal of Haematology , vol. 204 , no. 4 , pp. 1271-1278 . https://doi.org/10.1111/bjh.19194Test

مصطلحات موضوعية: CHOP, chemotherapy, clinical studies, late effects of therapy, non-Hodgkin lymphoma, Bone Density, Fractures, Compression/drug therapy, Humans, Middle Aged, Bendamustine Hydrochloride/adverse effects, Lymphoma, Follicular/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Prednisone/adverse effects, Vincristine/adverse effects, Rituximab/adverse effects, Spinal Fractures/drug therapy

العلاقة: https://pure.au.dk/portal/en/publications/c35bd821-3220-460c-a53c-62ee77c32693Test

الإتاحة: https://doi.org/10.1111/bjh.19194Test
https://pure.au.dk/portal/en/publications/c35bd821-3220-460c-a53c-62ee77c32693Test

المؤلفون: Knudsen, Anne-Dorthe Mosgaard, Modvig, Mikala Wej, Vogsen, Marianne, Kodahl, Annette Raskov

المصدر: Knudsen , A-D M , Modvig , M W , Vogsen , M & Kodahl , A R 2024 , ' Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer ' , Medical Oncology , vol. 41 , no. 5 , 99 . https://doi.org/10.1007/s12032-024-02356-yTest

مصطلحات موضوعية: Humans, Female, Capecitabine, Breast Neoplasms/pathology, Retrospective Studies, Treatment Outcome, Disease-Free Survival, Receptor, ErbB-2/metabolism, Antineoplastic Combined Chemotherapy Protocols/adverse effects

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/b9b6d46a-be55-4f9e-b169-1bea9192307cTest

الإتاحة: https://doi.org/10.1007/s12032-024-02356-yTest
https://portal.findresearcher.sdu.dk/da/publications/b9b6d46a-be55-4f9e-b169-1bea9192307cTest
https://findresearcher.sdu.dk/ws/files/258282280/s12032-024-02356-y.pdfTest

المؤلفون: Jerkeman, Mats, Kolstad, Arne, Hutchings, Martin, Pasanen, Annika, Meriranta, Leo, Niemann, Carsten Utoft, Kragh Jørgensen, Rasmus Rask, El-Galaly, Tarec Christoffer, Riise, Jon, Leppä, Sirpa, Christensen, Jacob Haaber, Sonnevi, Kristina, Pedersen, Lone Bredo, Wader, Karin Fahl, Glimelius, Ingrid

المصدر: Jerkeman , M , Kolstad , A , Hutchings , M , Pasanen , A , Meriranta , L , Niemann , C U , Kragh Jørgensen , R R , El-Galaly , T C , Riise , J , Leppä , S , Christensen , J H , Sonnevi , K , Pedersen , L B , Wader , K F & Glimelius , I 2024 , ' MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial ' , Blood advances , vol. 8 , no. 2 , pp. 407-415 . https://doi.org/10.1182/bloodadvances.2023011920Test

مصطلحات موضوعية: Adult, Humans, Aged, Lymphoma, Mantle-Cell, Rituximab/adverse effects, Lenalidomide/therapeutic use, Neoplasm, Residual/drug therapy, Neoplasm Recurrence, Local/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Sulfonamides, Bridged Bicyclo Compounds, Heterocyclic, Rituximab/therapeutic use

وصف الملف: application/pdf

العلاقة: https://vbn.aau.dk/da/publications/e1016e94-29e3-4637-ba18-dd36853a40faTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2023011920Test
https://vbn.aau.dk/da/publications/e1016e94-29e3-4637-ba18-dd36853a40faTest
https://vbn.aau.dk/ws/files/638275389/Jerkeman_et_al._2024_._MRD-driven_treatment_with_venetoclax-R2_in_mantle_cell_lymphoma_-_the_Nordic_Lymphoma_Group_MCL7_VALERIA_trial.pdfTest

المؤلفون: Nakamura, Yoshiaki, Mizuno, Nobumasa, Sunakawa, Yu, Canon, Jean-Luc, Galsky, Matthew D, Hamilton, Erika, Hayashi, Hidetoshi, Jerusalem, Guy, Kim, Seung Tae, Lee, Keun-Wook, Kankeu Fonkoua, Lionel Aurelien, Monk, Bradley J, Nguyen, Danny, Oh, Do-Youn, Okines, Alicia, O'Malley, David M, Pohlmann, Paula, Reck, Martin, Shin, Sang Joon, Sudo, Kazuki, Takahashi, Shunji, Van Marcke, Cedric, Yu, Evan Y, Groisberg, Roman, Ramos, Jorge, Tan, Sherry, Stinchcombe, Thomas E, Bekaii-Saab, Tanios

المصدر: Journal of Clinical Oncology, 41 (36), 5569 - 5578 (2023-12-20)

مصطلحات موضوعية: Trastuzumab, ERBB2 protein, human, tucatinib, Antibodies, Monoclonal, Humanized, Receptor, ErbB-2, Humans, Trastuzumab/adverse effects, Receptor, ErbB-2/metabolism, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Neoplasms, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

العلاقة: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.00606Test; urn:issn:0732-183X; urn:issn:1527-7755

الوصول الحر: https://orbi.uliege.be/handle/2268/313195Test

المؤلفون: Jerusalem, Guy, Prat, Aleix, Salgado, Roberto, Reinisch, Mattea, Saura, Cristina, Ruiz-Borrego, Manuel, Nikolinakos, Petros, Ades, Felipe, Filian, Jeiry, Huang, Ning, Mazzei-Abba, Antonella, Tolaney, Sara M

المصدر: Breast, 72, 103580 (2023-12)

مصطلحات موضوعية: Anastrozole, Aromatase inhibitors, Breast neoplasms, Cyclin-dependent kinases, Immune checkpoint inhibitors, Neoadjuvant therapy, Nivolumab, Patient safety, Programmed cell death 1 receptor, ERBB2 protein, human, palbociclib, Receptor, ErbB-2, Receptors, Estrogen, Female, Humans, Neoadjuvant Therapy, Pneumonia, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Breast Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Surgery, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

العلاقة: urn:issn:0960-9776; urn:issn:1532-3080

الوصول الحر: https://orbi.uliege.be/handle/2268/313197Test

المؤلفون: Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, Huls, Gerwin, EORTC Leukemia Group

المصدر: The Lancet Haematology, 10 (11), e879 - e889 (2023-11)

مصطلحات موضوعية: Decitabine, Cytarabine, Daunorubicin, Humans, Middle Aged, Aged, Decitabine/therapeutic use, Cytarabine/therapeutic use, Daunorubicin/therapeutic use, Transplantation, Homologous, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Leukemia, Myeloid, Acute/drug therapy, Leukemia, Myeloid, Acute/diagnosis, Hematology, Human health sciences, Sciences de la santé humaine, Hématologie

العلاقة: https://api.elsevier.com/content/article/PII:S2352302623002739?httpAccept=text/xmlTest; urn:issn:2352-3026

الوصول الحر: https://orbi.uliege.be/handle/2268/308889Test

المؤلفون: Vergote, Ignace, González-Martín, Antonio, Fujiwara, Keiichi, Kalbacher, Elsa, Bagaméri, Andrea, Ghamande, Sharad, Lee, Jung-Yun, Banerjee, Susana, Maluf, Fernando Cotait, Lorusso, Domenica, Yonemori, Kan, Van Nieuwenhuysen, Els, Manso, Luis, Woelber, Linn, Westermann, Anneke, Covens, Allan, Hasegawa, Kosei, Kim, Byoung-Gie, Raimondo, Miriam, Bjurberg, Maria, Cruz, Felipe Melo, Angelergues, Antoine, Cibula, David, Barraclough, Lisa, Oaknin, Ana, Gennigens, Christine, Nicacio, Leo, Teng, Melinda Siew Leng, Whalley, Elizabeth, Soumaoro, Ibrahima, Slomovitz, Brian M, innovaTV 301/ENGOT-cx12/GOG-3057 Collaborators

المصدر: New England Journal of Medicine, 391 (1), 44 - 55 (2024-07-04)

مصطلحات موضوعية: Antibodies, Monoclonal, Humans, Female, Middle Aged, Adult, Aged, Kaplan-Meier Estimate, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/administration & dosage, Survival Analysis, Progression-Free Survival, Aged, 80 and over, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/mortality, Neoplasm Recurrence, Local/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

العلاقة: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2313811Test; urn:issn:0028-4793; urn:issn:1533-4406

الوصول الحر: https://orbi.uliege.be/handle/2268/320411Test

المساهمون: Min Kyeong Jang, Seho Park, Chang Park, Ardith Doorenbos, Jieon Go, Sue Kim, Kim, Sue

مصطلحات موضوعية: Anemia* / chemically induced OR Anemia* / drug therapy OR Anemia* / epidemiology OR Antineoplastic Combined Chemotherapy Protocols / adverse effects OR Body Composition OR Breast Neoplasms* / drug therapy OR Breast Neoplasms* / etiology OR Female OR Humans OR Neoadjuvant Therapy / adverse effects OR Neutropenia* / chemically induced OR Neutropenia* / drug therapy OR Neutropenia* / epidemiology OR Retrospective Studies OR Sarcopenia* / chemically induced OR Sarcopenia* / epidemiology OR Thrombocytopenia* / drug therapy, Body composition, Breast neoplasm, Muscle/skeletal, Neoadjuvant chemotherapy, Sarcopenia

العلاقة: SUPPORTIVE CARE IN CANCER; J02697; OAK-2023-02751; OAK-2023-02752; https://ir.ymlib.yonsei.ac.kr/handle/22282913/196174Test; https://link.springer.com/article/10.1007/s00520-023-07890-5Test; T202304589; SUPPORTIVE CARE IN CANCER, Vol.31(7) : 419, 2023-07

الإتاحة: https://doi.org/10.1007/s00520-023-07890-5Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/196174Test